Evidence map›Paper›PMID 41368186›Full record

ArticleBlood cell therapy2025

Feasibility of early tacrolimus initiation in haploidentical-PBSCT with post-transplant cyclophosphamide after melphalan-based conditioning regimen.

Wataru Kitamura, Toshiki Terao, Ken-Ichi Matsuoka, Takumi Kondo, Keisuke Seike, Keiko Fujii, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Nobuharu Fujii and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cell therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wataru KitamuraDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Toshiki TeraoDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Ken-Ichi MatsuokaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Takumi KondoDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Keisuke SeikeDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Keiko FujiiDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Hideaki FujiwaraDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Noboru AsadaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Daisuke EnnishiDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Nobuharu FujiiDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Yoshinobu MaedaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide (PTCy-haplo), early initiation of calcineurin inhibitors may affect transplant outcome by inducing CD8

Indexed as

haploidenticalmelphalan, tacrolimusperipheral blood stem cell transplantationpost-transplant cyclophosphamide

Identifiers

PMID41368186
PMCPMC12682609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.